Home > Protocol Summaries: Compounds > GSK221149 Protocol Summaries: GSK221149 GSKStudy ID Phase Title Status OTA105101 Phase 1 An open-label, two period study to determine the excretion balance and pharmacokinetics of [14C]-GSK221149A, administered as single doses of an oral solution and an intravenous infusion to healthy female volunteers Completed OTA106004 Phase 1 A two-part, open-label, cross-over study to assess the pharmacokinetics of GSK221149 following single oral doses of various modified release formulations and a solution in healthy adult subjects Terminated OTP108172 Phase 2 A randomized, double-blind, placebo-controlled, two-session study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of an 16448 in healthy males with premature ejaculation. Completed
